MP

Michel Perricaudet

AS Aventis Pharma S.A.: 4 patents #3 of 104Top 3%
CN CNRS: 3 patents #2 of 230Top 1%
IR Institut Gustave Roussy: 1 patents #1 of 10Top 10%
IP Institut Pasteur: 1 patents #10 of 102Top 10%
UC University Of British Columbia: 1 patents #16 of 89Top 20%
📍 Rambouillet, FR: #1 of 14 inventorsTop 8%
Overall (2004): #3,653 of 270,089Top 2%
7
Patents 2004

Issued Patents 2004

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
6814962 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same Patrick Benoit, Patrice Denefle, M. E. Suzanne Lewis, Michael Hayden 2004-11-09
6811774 Defective recombinant adenoviruses expressing cytokines for antitumor treatment Hedi Haddada, Thierry Ragot 2004-11-02
RE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias Patrick Benoit, Patrice Denefle, Sandrine Seguret, Emmanuelle Vigne 2004-07-13
6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain Axel Kahn, Gildas Le Gal La Salle, Jacques Mallet, Marc Peschanski, Jean-Jacques Robert 2004-06-29
6743623 Viral recombinant vectors for expression in muscle cells Pascale Briand, Leslie Stratford-Perricaudet 2004-06-01
6696420 Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein Annick Ballay, Massimo Levredo, Pierre Tiollais 2004-02-24
6685934 Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF) Jacques Mallet, Emmanuelle Vigne, Frederic Revah, Marc Abitbol, Paul Roustan 2004-02-03